Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
45,989,019
-
Shares change
-
+5,906,750
-
Total reported value, excl. options
-
$5,412,737,939
-
Value change
-
+$716,635,309
-
Put/Call ratio
-
39%
-
Number of buys
-
88
-
Number of sells
-
53
-
Price
-
$117.70
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2019
As of 31 Mar 2019 Ascendis Pharma A/S - ADR (ASND) had 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,989,019 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Vivo Capital, LLC, Avoro Capital Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 137 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.